anmelden
25 € WM-Startbonus auf dein Cash-Konto
NYSE International 100
10.875,82
PKT
+52,25
PKT
+0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.04.26 | Diageo Buy | Jefferies & Company Inc. | |
| 01.04.26 | Unilever Outperform | Bernstein Research | |
| 01.04.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 01.04.26 | Philips Neutral | JP Morgan Chase & Co. | |
| 01.04.26 | Diageo Overweight | Barclays Capital | |
| 01.04.26 | BP Overweight | Barclays Capital | |
| 01.04.26 | National Grid Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Unilever Outperform | Bernstein Research | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Philips Market-Perform | Bernstein Research | |
| 31.03.26 | Eni Buy | UBS AG | |
| 31.03.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Underperform | RBC Capital Markets | |
| 31.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 31.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 31.03.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Mercedes-Benz Group (ex Daimler) Market-Perform | Bernstein Research | |
| 31.03.26 | TotalEnergies Overweight | Barclays Capital | |
| 31.03.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 31.03.26 | BP Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | GSK Underweight | Barclays Capital | |
| 31.03.26 | Diageo Buy | Deutsche Bank AG | |
| 31.03.26 | Diageo Buy | Deutsche Bank AG | |
| 31.03.26 | Eni Overweight | Barclays Capital | |
| 31.03.26 | Philips Overweight | Barclays Capital | |
| 31.03.26 | Eni Buy | Jefferies & Company Inc. | |
| 31.03.26 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 30.03.26 | Rio Tinto Equal-weight | Morgan Stanley | |
| 30.03.26 | Sanofi Neutral | UBS AG | |
| 30.03.26 | Novartis Buy | Deutsche Bank AG | |
| 30.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.03.26 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 30.03.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.03.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.03.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 27.03.26 | Siemens Buy | UBS AG | |
| 27.03.26 | AstraZeneca Overweight | Barclays Capital |